BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37307823)

  • 21. PDGF-BB-mediated activation of p42(MAPK) is independent of PDGF beta-receptor tyrosine phosphorylation.
    Cartel NJ; Liu J; Wang J; Post M
    Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L786-98. PubMed ID: 11557582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDGF-BB regulates the transformation of fibroblasts into cancer-associated fibroblasts via the lncRNA LURAP1L-AS1/LURAP1L/IKK/IκB/NF-κB signaling pathway.
    Ren X; Li L; Wu J; Lin K; He Y; Bian L
    Oncol Lett; 2021 Jul; 22(1):537. PubMed ID: 34079593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.
    Aoki M; Nabeshima K; Koga K; Hamasaki M; Suzumiya J; Tamura K; Iwasaki H
    Lab Invest; 2007 Aug; 87(8):767-79. PubMed ID: 17558420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma.
    Itou RA; Uyama N; Hirota S; Kawada N; Wu S; Miyashita S; Nakamura I; Suzumura K; Sueoka H; Okada T; Hatano E; Tsutsui H; Fujimoto J
    Hum Pathol; 2019 Jan; 83():77-89. PubMed ID: 30172911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-derived growth factor receptor-beta, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma.
    Suzuki S; Heldin CH; Heuchel RL
    BMC Cancer; 2007 Dec; 7():224. PubMed ID: 18076756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of platelet-derived growth factor receptor β is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis.
    Miyazaki H; Yoshimatsu Y; Akatsu Y; Mishima K; Fukayama M; Watabe T; Miyazono K
    Cancer Sci; 2014 Sep; 105(9):1116-23. PubMed ID: 24981766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation.
    Smoot RL; Werneburg NW; Sugihara T; Hernandez MC; Yang L; Mehner C; Graham RP; Bronk SF; Truty MJ; Gores GJ
    J Cell Biochem; 2018 Jan; 119(1):824-836. PubMed ID: 28661054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment.
    Zhou Y; Xu L; Wang Z; Liu H; Zhang X; Shu C; Zhang M; Wang T; Xu X; Pu X; He J; Wang P; Qiu Y; Xu G; Zou X; Zhu Y; Wang L
    Theranostics; 2022; 12(8):3911-3927. PubMed ID: 35664077
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells.
    Wei WF; Zhou HL; Chen PY; Huang XL; Huang L; Liang LJ; Guo CH; Zhou CF; Yu L; Fan LS; Wang W
    J Exp Clin Cancer Res; 2023 Jul; 42(1):160. PubMed ID: 37415190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal integrin α11 regulates PDGFR-β signaling and promotes breast cancer progression.
    Primac I; Maquoi E; Blacher S; Heljasvaara R; Van Deun J; Smeland HY; Canale A; Louis T; Stuhr L; Sounni NE; Cataldo D; Pihlajaniemi T; Pequeux C; De Wever O; Gullberg D; Noel A
    J Clin Invest; 2019 Jul; 129(11):4609-4628. PubMed ID: 31287804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling.
    Duan HX; Li BW; Zhuang X; Wang LT; Cao Q; Tan LH; Qu GF; Xiao S
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G763-G773. PubMed ID: 30920845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in
    Duangdara J; Boonsri B; Sayinta A; Supradit K; Thintharua P; Kumkate S; Suriyonplengsaeng C; Larbcharoensub N; Mingphruedhi S; Rungsakulkij N; Muangkaew P; Tangtawee P; Vassanasiri W; Suragul W; Janvilisri T; Tohtong R; Bates DO; Wongprasert K
    Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38275995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma.
    Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q
    Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells.
    Chen YC; Chang CN; Hsu HC; Chiou SJ; Lee LT; Hseu TH
    Life Sci; 2009 Jun; 84(25-26):915-22. PubMed ID: 19393247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium butyrate inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells.
    Ranganna K; Joshi T; Yatsu FM
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2273-83. PubMed ID: 7489253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Kit and platelet-derived growth factor receptors alpha and beta in cholangiocarcinoma, and case report of therapy with imatinib mesylate (STI571).
    Holcombe RF; Gu M; Imagawa D; Milovanovic T
    Anticancer Drugs; 2003 Sep; 14(8):651-7. PubMed ID: 14501388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancer.
    Liu J; Liu C; Qiu L; Li J; Zhang P; Sun Y
    Diagn Pathol; 2014 Jun; 9():128. PubMed ID: 24972450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An HGF-dependent positive feedback loop between bladder cancer cells and fibroblasts mediates lymphangiogenesis and lymphatic metastasis.
    Li Y; Zheng H; Luo Y; Lin Y; An M; Kong Y; Zhao Y; Yin Y; Ai L; Huang J; Chen C
    Cancer Commun (Lond); 2023 Dec; 43(12):1289-1311. PubMed ID: 37483113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-206 suppresses the deterioration of intrahepatic cholangiocarcinoma and promotes sensitivity to chemotherapy by inhibiting interactions with stromal CAFs.
    Yang R; Wang D; Han S; Gu Y; Li Z; Deng L; Yin A; Gao Y; Li X; Yu Y; Wang X
    Int J Biol Sci; 2022; 18(1):43-64. PubMed ID: 34975317
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiation-induced effects on TGF-β and PDGF receptor signaling in cancer-associated fibroblasts.
    Yang N; Hellevik T; Berzaghi R; Martinez-Zubiaurre I
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2018. PubMed ID: 38488488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.